Gartner Blog Network


“Accelerating R&D” Key Initiatives for Life Science Manufacturers 2016

by Michael Shanler  |  January 27, 2016  |  Comments Off on “Accelerating R&D” Key Initiatives for Life Science Manufacturers 2016

Before each calendar year begins, we put a lot of effort into outlining areas of research and how these areas align with strategic key initiatives (KIs).  The life science-related  KIs for CIOs and IT leaders have been broken into several disciplined areas:

  1. Commercial (i.e. How to more effectively market optimal therapies and services to different customers (patients, payers, providers, etc.)
  2. Accelerating innovation. (i.e. How to get a new innovation – drug, service, technology or product – to market faster?)
  3. Supply Chain (SC) (i.e. How to intelligently manufacture high quality products with compliance?)

Gartner Asset

For R&D-related KI details, read:  Accelerating R&D and New Product Innovation in Life Sciences Primer for 2016 26 January 2016  G00292958

Commercial is covered by Stephen Davies.  Supply Chain quality, manufacturing and serialization, etc is covered by a host of other SC analysts.  I’m the lead for the R&D KI.  This year, I’m planning on breaking up the R&D-related research (research notes, surveys, executive briefing decks, workshops, presentations etc.)  into the topics below. While these will mostly be contextualized for life science (pharma, biotech, medical device, CROs, etc.), a lot of this material translates reasonably well into other scientific-domain manufacturing environments (crop science, materials, cosmetics, food and beverage, etc.)

R&D Tech Trends and Cool stuff:

  • Hype Cycle for Life Sciences, 2016
  • Cool Vendors in Life Sciences, 2016
  • Life Science Business Drivers
  • Top 10 Technology Opportunities for Pharma

R&D IT productivity:

  • Life Science CIO R&D IT Blueprint
  • Digital Strategy Development and Best Practices
  • Analytics and BI Maturity in Life Science
  • Embracing “Shadow IT” as Partners, Not Adversaries

Laboratory IT:

  • Laboratory of the Future
  • ELN/LIMS Maturity Model & Best Practices
  • Laboratory Informatics Market Guide for ELN/LIMS
  • Mind the Laboratory IT Service Gap

Clinical Development:

  • E-Clinical Systems Evolution
  • Patient Engagement and Mobile Apps in Clinical Trials
  • What’s Your Reality for Real-World Evidence (RWE)?
  • Identification of Medicinal Product (IDMP)…which was just published.

R&D while meeting regulatory compliance:

  • Regulated vs Non Regulated ECM Tug of War
  • Clinical Trial Data Transparency Readiness
  • RIMS Vendors Overview
  • eTMF Maturity

Of course, we’ll also contribute in special reports (IoT, 3D Printing, Digital Business, Industry Fluidity), manage tech profiles going into a bunch of related hype cycles (e.g. Healthcare, 3D Printing, PLM, Supply Chain), and stay on top of “first takes” for events and vendor M&A activities.

Yikes!   Time is flying. We are already burned through 1/12 of 2016.  Back to the research….

Additional Resources

Category: 3d-printing  additive-manufacturing  analytics  clinical-development  compliance  ctms  data-and-analytics-strategies  digital-marketing  eclinical  edc  engineering  epro  gartner  innovation  internet-of-everything  internet-of-things  iot  it  it-cost-optimization  manufacturing  mobile-and-endpoint-technologies  nexus-of-forces  nof  pharma  pharmaceutical  product-development  rd  regulatory  science  security  supply-chain  technology-and-emerging-trends  trends-and-predictions  wearables  

Tags: cloud  collaboration  digital-business  ea  innovation  it-governance  

Michael Shanler
Research VP
5 years at Gartner

Michael Shanler covers life science R&D technologies. Read Full Bio




Comments are closed

Comments or opinions expressed on this blog are those of the individual contributors only, and do not necessarily represent the views of Gartner, Inc. or its management. Readers may copy and redistribute blog postings on other blogs, or otherwise for private, non-commercial or journalistic purposes, with attribution to Gartner. This content may not be used for any other purposes in any other formats or media. The content on this blog is provided on an "as-is" basis. Gartner shall not be liable for any damages whatsoever arising out of the content or use of this blog.